MRSO, Inc. (5619) AI Stock Analysis

• Market Cap: ¥3.98B
• Dividend Yield: N/A
• Average Volume (3M): 3.15K
• Price to Earnings (P/E): 946.8
• Beta (1Y): 0.03
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: JP
• Employees: 21
• Sector: Services
• Sector Strength: N/A
• Industry: Software - Application
• EPS (TTM): -5.42
• Shares Outstanding: 3,552,750
• 10 Day Avg. Volume: 2,790
• 30 Day Avg. Volume: 3,146
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥1,130.00
• Price Target Upside: 5.90% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 56 Neutral
• Price Target: ¥1,130.00 ▲(5.90% Upside)

The overall stock score is primarily impacted by MRSO, Inc.'s financial challenges, including declining revenue and profitability along with cash flow issues. While technical analysis shows positive momentum, the extremely high P/E ratio suggests overvaluation, affecting the stock's appeal. The absence of earnings call and corporate events data limits further insights.

MRSO, Inc. Business Overview & Revenue Model

Company Description

MRSO, Inc. (5619) is a technology-driven company specializing in the development and manufacturing of innovative solutions within the healthcare sector. The company focuses on creating advanced medical devices and software solutions designed to improve patient outcomes and streamline healthcare operations. MRSO, Inc. operates in various segments, including diagnostics, patient monitoring, and healthcare information management, providing a comprehensive suite of products and services aimed at healthcare providers and institutions.

How the Company Makes Money

MRSO, Inc. generates revenue primarily through the sale of its medical devices and software solutions to healthcare providers, hospitals, and clinics. The company employs a direct sales model complemented by partnerships with distributors to expand its market reach. Key revenue streams include product sales, recurring revenue from software subscriptions and service contracts, and consulting services for healthcare systems. Additionally, MRSO, Inc. benefits from strategic partnerships with other technology firms and healthcare organizations, which enhance its product offerings and market position, contributing significantly to its earnings.

MRSO, Inc. Financial Statement Overview

Summary

MRSO, Inc. is experiencing a challenging financial period with declining revenues and profitability indicators. The strong balance sheet provides a buffer against financial instability, but negative cash flow trends pose significant risks if not addressed.

Income Statement

MRSO, Inc. has experienced a significant decline in revenue over the past three years, with a notable drop from 2022 to 2024. The gross profit margin remains strong at approximately 77% for 2024, indicating effective cost management. However, the net profit margin has declined to 7.6% in 2024, reflecting reduced profitability. Both EBIT and EBITDA margins have also decreased significantly, showing challenges in operational efficiency.

Balance Sheet

The company's balance sheet remains robust with a high equity ratio of 89.6% in 2024, indicating strong capitalization. The debt-to-equity ratio is extremely low at 0.003, showcasing minimal leverage risk. Return on equity has decreased to 5% in 2024, suggesting reduced profitability relative to shareholders' equity, but the overall financial position is stable.

Cash Flow

MRSO, Inc. has shown a concerning trend in cash flow with negative operating cash flow and free cash flow in 2024, signaling potential liquidity issues. The free cash flow to net income ratio is negative, highlighting the inability to convert net income into cash. This trend raises concerns about cash management and sustainability.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	1.33B	1.81B	2.25B	1.74B
Gross Profit	1.03B	1.45B	1.79B	1.35B
EBITDA	163.77M	612.32M	1.01B	914.67M
Net Income	101.00M	387.55M	653.83M	650.88M
Balance Sheet
Total Assets	2.26B	2.25B	2.08B	1.70B
Cash, Cash Equivalents and Short-Term Investments	1.81B	1.93B	1.74B	1.42B
Total Debt	7.00M	15.36M	23.35M	31.34M
Total Liabilities	234.45M	373.01M	744.00M	655.32M
Stockholders Equity	2.02B	1.88B	1.34B	1.04B
Cash Flow
Free Cash Flow	-77.63M	43.06M	695.05M	1.10B
Operating Cash Flow	-77.63M	48.28M	696.31M	1.11B
Investing Cash Flow	-59.69M	-8.31M	-1.43M	-12.95M
Financing Cash Flow	22.89M	144.36M	-367.99M	-7.99M

MRSO, Inc. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1067.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:5619, the sentiment is Positive. The current price of 1067 is above the 20-day moving average (MA) of 1051.30, above the 50-day MA of 1020.00, and above the 200-day MA of 994.60, indicating a bullish trend. The MACD of 30.25 indicates Negative momentum. The RSI at 63.50 is Neutral, neither overbought nor oversold. The STOCH value of 71.15 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:5619.

MRSO, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3744	76 Outperform	¥4.77B	10.65		1.39%	-7.06%	147.27%
4447	72 Outperform	¥3.86B	19.93		1.73%	42.88%	-5.21%
6633	67 Neutral	¥3.15B	11.50		3.03%	2.65%	78.23%
3710	61 Neutral	¥3.05B	27.91		1.02%	-6.71%	―
3909	56 Neutral	¥3.46B	14.20		―	13.97%	―
5619	56 Neutral	¥3.98B	946.83		―	―	―
Sector *	54 Neutral	C$44.81M	57.91	15.08%	4.51%	1.39%	-26.37%